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BACKGROUND: Post-transcriptional modiﬁcation by SUMOylation is involved in numerous cellular processes
including human spermatogenesis. For human male meiosis, we previously showed that the small ubiquitin-related
modiﬁer-1 (SUMO-1) protein localizes to chromatin axes in early pachytene spermatocytes, then to kinetochores as
meiosis progresses. Here, we delineate possible functional roles based on subcellular localization for SUMO-1 and
SUMO-2/3. METHODS: Western and immunoprecipitation analyses were conducted on proteins isolated from the
testis of two normal adult fertile men. Combinatorial immunoﬂuorescence and chromosome-speciﬁc ﬂuorescence in
situ hybridization analyses were performed on male meiocytes obtained during testicular biopsy from four patients
undergoing testicular sperm extraction for assisted reproduction technologies. RESULTS: The synaptonemal
complex (SC) and SC proteins (SCP)-1 and SCP2, but not SCP3, are SUMOylated by SUMO-1 during the pachytene
substage. Likewise, two distinct localization patterns for SUMO-1 are identiﬁed: a linear pattern co-localized with
autosomal SCs and isolated SUMO-1 near the centromeric heterochromatin of chromosomes 9 and 1. In contrast
to SUMO-1, which is not detectable prior to pachytene in normal tissue, SUMO-2/3 is identiﬁed as early as leptotene
and zygotene and in some, but not all, pachytene cells; no linear patterns were detected. Similar to SUMO-1, SUMO-
2/3 localizes in two predominant subnuclear patterns: a single, dense signal near the centromere of human chromo-
some 9 and small, individual foci co-localized with autosomal centromeres. CONCLUSIONS: Our data suggest that
SUMO-1 may be involved in maintenance and/or protection of the autosomal SC. SUMO-2/3, though expressed simi-
larly, may function separately and independently during pachytene in men.
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Introduction
The incidence of infertility among couples in North America
and Europe ranges from 5% to 15% depending on the clinical
deﬁnitions used; up to 50% have a male factor that contributes
to infertility (Hull et al., 1985; Forti and Krausz, 1998). Male
factors include testicular stem cell defects, abnormalities of
meiosis and defects of sperm function. In men, meiosis
begins with the onset of puberty and spermatogenesis.
Meiosis is the specialized cellular division in which each
diploid cell replicates its DNA once but undergoes two
rounds of cell division to form four haploid sperm. Meiosis I
is hallmarked by three unique events: pairing of duplicated,
homologous chromosomes, formation of the synaptonemal
complex (SC) and exchange of genetic material (recombina-
tion), all occurring during meiotic prophase.
New molecular mechanisms involved in the regulation of the
meiotic process are being identiﬁed. One such novel process is
SUMOylation, and the recent identiﬁcation of the small
ubiquitin-related modiﬁer-1 (SUMO-1) protein during the
pachytene substage of prophase suggests an involvement of
SUMOylation in these events in men (Vigodner et al., 2006).
Recent studies in budding yeast and mammals demonstrate
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Advance Access publication on August 10, 2008the presence of SUMO proteins in meiotic cells, ﬁndings sug-
gestive of specialized roles for SUMO and SUMOylation (Yan
et al., 2003; Rogers et al., 2004; Vigodner and Morris, 2005;
Yamaguchi et al., 2005; Hooker and Roeder, 2006; Sacher
et al., 2006; Vigodner et al., 2006).
SUMOylation is a reversible post-translational modiﬁcation
involved in numerous essential processes. SUMOs are a family
of eukaryotic proteins frequently associated with transcriptional
regulation, protein–protein interactions, heterochromatin modi-
ﬁcations and DNA repair (Sapetschnig et al., 2002; Vigodner
and Morris, 2005; Di Bacco et al., 2006; Vigodner et al., 2006;
Yurchenko et al., 2006). To date, there are four mammalian
SUMO proteins, SUMO-1, -2, -3 and -4, which upon activation
covalentlybondtoalysineresidueonatargetproteinthroughthe
action of speciﬁc activators and conjugating enzymes (Schwarz
et al., 1998; Azuma et al., 2001, 2003; Tatham et al., 2001).
Differential activation suggests both target and process-speciﬁc
regulation (Sapetschnig et al., 2002). SUMO-1 shares 48%
and 46% amino acid sequence identity with SUMO-2 and
SUMO-3, respectively, which are members of a subfamily
(SUMO-2/3) based on their 95% shared amino acid sequence
and similar conjugation pathway (Saitoh and Hinchey, 2000).
Recent studies in budding yeast show that SUMOylation is
associated with meiotic speciﬁc events—formation of the SC
(Cheng et al., 2006; Hooker and Roeder, 2006) and homolo-
gous recombination (Sacher et al., 2006). The role(s) of
SUMO(s) in mammalian meiosis remain undeﬁned. SUMO-1
has been identiﬁed in both human and rodent spermatocytes,
ﬁndings suggestive of a similar role in mammals (Yan et al.,
2003; Rogers et al., 2004; Vigodner and Morris, 2005; Yama-
guchi et al., 2005; Sacher et al., 2006; Vigodner et al., 2006).In
rodents, SUMO-1 is associated exclusively with the sex body
during pachytene similar to the association of g-H2AX and
BRCA1, associations postulated to function in meiotic sex
chromosome inactivation necessary to silence unpaired
chromosomes (Rogers et al., 2004; Turner et al., 2004;
Vigodner and Morris, 2005).
Using immunoﬂuorescence (IF) microscopy and chromo-
some-speciﬁc ﬂuorescence in situ hybridization (FISH), we
identiﬁed interaction(s) between individual SUMO proteins,
SUMO-1 and SUMO-2/3, and the SC in over 1200 human sper-
matocytes. The present study further characterizes SUMO-1
when compared with SUMO-2/3 in human male meiosis by
using a meiotic event, namelythe formationof the SC, as a devel-
opmental guide. To our knowledge, our studies provide the ﬁrst
report of SUMO-2/3 expression in human spermatocytes.
Materials and Methods
Human testicular samples
Testicular samples were obtained, under ongoing Institutional Review
Board approval and individual informed consent for the use of dis-
carded tissue, from four individuals undergoing evaluation at Weill
Cornell Medical Center for the treatment of azoospermia. Testicular
tissue was procured by biopsy for the purpose of testicular sperm
extraction (TESE) for ICSI from patients diagnosed with non-
obstructive or obstructive azoospermia (Palermo et al., 1999;
Schlegel, 1999). Biopsy samples of normal tissue were obtained
from otherwise healthy individuals with normal spermatogenesis,
but with reproductive tract obstruction because of congenital
absence of the vas, or post-vasectomy.
Sample processing, IF and FISH
Cells obtained from testicular tissue were processed using an air-dried
technique with the following modiﬁcations of a previously described
protocol (Barlow and Hulte ´n, 1996). Microscope slides were washed
in 0.04% PhotoFlo solution (Eastman Kodak, Rochester, NY, USA)
for 2 min, drained and air-dried. Once dried, slides were hydrated for
at least 30 min at room temperature (RT) in 1  antibody dilution
buffer [ADB; 1% normal donkey serum, 0.3% bovine serum albumin
and 0.005% Triton X in phosphate-buffered saline (PBS); Sigma].
For IF, slides were overlaid with a primary anti-sera cocktail—combi-
nations of anti-serum to centromeres (1:1000; Antibodies, Inc., Davis
CA, USA), speciﬁc SC proteins, namely, SC protein (SCP)3 (1:100;
a gift from Dr Terry Ashley, Yale University, CT, USA) or SCP1
(1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
SUMO-1 (1:100; Afﬁnity BioReagents, Golden, CO, USA),
SUMO-2/3 (1:100; Cell Signaling Technology, Danvers, MA, USA)
or MLH1, a mismatch repair protein (1:75; Calbiochem, San Diego,
CA, USA) and coverslips applied for incubations overnight (378C;
humid chamber). Following the incubation of the primary antibodies,
slides were washed for 20 min at RT in 1  ADB followed by a
secondwashin1  ADBat48Cfor5–16 htoprepareforthesecondary
antibodies. Slides were then incubated at 378C for 90 min in a humid
chamber with the secondary antibody cocktail—AMCA donkey anti-
human immunoglobulin (Ig)G, Texas Red donkey anti-goat IgG and
ﬂuorescein isothiocyanate-conjugated donkey anti-rabbit IgG (1:100;
Jackson ImmunoResearch Laboratories, Bar Harbor, ME, USA).
Slides were washed 3  in PBS at RT for 10 min each, immediately
mounted in Antifade (BioRad Laboratories, Hercules, CA, USA) and
coverslip applied. To further conﬁrm the speciﬁcity of the antisera,
neutralization experiments were conducted as follows: 2 mg recombi-
nant SUMO protein/ml of antibody was pre-incubated (45 min; RT)
prior to hybridization. Slides were stored (48C) until microscopic
analysis.
Using a wide-ﬁeld ﬂuorescence Zeiss Axioplan 2 microscope (Carl
Zeiss, Thornwood, NY, USA), spermatocytes were identiﬁed, cap-
tured for further analysis using a Hamamatsu Orca ER B/W digital
camera (Hamamatsu, Bridgewater, NJ, USA) and coordinates noted
for subsequent FISH analyses. All images were captured using a
100  objective and processed using MetaVue acquisition software
(Molecular Devices, Sunnyvale, CA, USA).
For chromosomes 1 and 9 dual FISH analysis, previously immuno-
labeled and analyzed slides were hybridized with probes based on
modiﬁcations of the manufacturer’s protocol. Brieﬂy, slides were
reﬁxed in 70% formamide (Ambion, Austin, TX, USA) in 2  stan-
dard saline citrate (SSC) at 738C for 5 min and dehydrated at RT in
serial ethanol dilutions of 70%, 85% and 100% ethanol for 1 min
each. Slides were allowed to air dry. To each slide, 10 ml of probe
mix (1 ml of CEP 1 and CEP 9 centromeric probes for respective
chromosomes, 7 ml hybridization buffer and 1 mlH 2O) was applied.
Slides were incubated overnight in a humid chamber (378C). Follow-
ing hybridization, slides underwent several 5 min washes (738C): ﬁrst,
50% formamide in 2  SSC allowing coverslip removal; second, 1 
SSC wash followed by 4  SSC/0.1% Tween-20. Next, slides were
immediately overlaid with Antifade with 4,6-diamidino-2-phenylin-
dole dihydrochloride (Sigma) counterstain and coverslip applied.
FISH-labeled cells identiﬁed in the prior pachytene analyses were
re-located and re-captured using the same microscope settings and
imaging software.
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Over 100 cells from each sample were analyzed for SUMO-1 and
SUMO-2/3.IFpatternsweredeterminedanddatacompiled;chi-square
tests were performed using the online Interactive Chi-Square Tests
(University of Kansas, Lawrence, KS, USA) to compare pattern fre-
quencies between individuals (see Supplementary Data).
Protein extraction, immunoprecipitation and Western analysis
For protein and SUMOylation analyses using immunoprecipitation
(IP) methods, total protein lysates were prepared from normal
human testis, obtained from the whole testis of normal adult men
(26 and 27 years of age; hT1; hT2, respectively). The protein concen-
tration was determined by the Bradford assay (BioRad). Individual
sets of protein lysates were used for IP experiments and Western ana-
lyses. The equally split sample (500 mg each) of each protein lysate
was diluted in 500 ml of TPER extraction reagent (PIERCE, Rockford,
IL, USA) with protease inhibitors at a ﬁnal concentration of 1 mM
dithiothreitol (DTT), 1 mM Na3VO4, 0.5 mM phenylmethylsulfonyl
ﬂuoride and 2 mg/ml aprotinin, pepstein, leupeptin (Sigma). To
each set of protein lysate or no-protein-lysate sample, either 5 mlo f
anti-SUMO-1 (21C7; Zymed, Carlsbad, CA, USA) or 5 mlo f
anti-SCP1 (Novus, Littleton, CO, USA) antisera was added. The
SUMO-1 epitope recognized by monoclonal antibody 21C7 is
absent in SUMO-2/3 and the antibody detects only SUMO-1, as
demonstrated previously in studies with these three human SUMO
proteins (Matunis et al., 1996; Saitoh and Hinchey, 2000), providing
further assurance of speciﬁcity. In parallel, the lysate and antibody
mixtures were incubated overnight with gentle agitation (48C).
Speciﬁc antibodies were captured by incubation with 50 mlo f
EZView Red
w protein A Afﬁnity Gel (Sigma) (1.5 h at 48C). The
beads were then washed three times using the TPER reagent and cen-
trifugation (30 s, 8200g). The pellets were then dissolved in 50 mlo f
NuPAGE
w LDS sample buffer (Invitrogen, Carlsbad, CA, USA),
with DTT (50 mM), and boiled for 5 min. The proteins in each immu-
noselected sample were subjected to separation by polyacrylamide gel
electrophoresis (PAGE). Using an aliquot (25 ml) of each collected
sample, the proteins were separated by PAGE using both 10%
NuPAGE Bis–Tris and 3–8% NuPAGE–Tris-acetate gels (Invitro-
gen). The immunoselected and separated proteins were then trans-
ferred to nitrocellulose membranes (Schleicher & Schuell, Keene,
NH, USA). For Western analysis, each membrane was sequentially
probed using speciﬁc primary antibodies in 5% non-fat dry milk
(BioRad)/1  Tris-buffered saline/1% Tween-20 (overnight, 48C).
For sequential immunoblotting, the absence of carry-over residual
signals was conﬁrmed before the particular membrane was re-probed.
For Western analyses, the primary antibodies used were SCP1
(T-17), SCP2 (K-13) (Santa Cruz, Santa Cruz, CA, USA) and SCP3
(BD Biosciences, Franklin Lakes, NJ, USA or Novus as indicated).
Immunoblots were developed using horse-radish peroxidase-
conjugated secondary antibody and ECL Plus
w Western blotting
reagents (Amersham Pharmacia Biotech, Buckinghamshire, UK) for
detection of speciﬁc signals.
Results
Analysis of SUMOylation in human spermatocytes
More than 1200 spermatocytes were analyzed using the testicu-
lar biopsy materials from TESE for patients with deﬁned testi-
cular histology. The precise localization of SUMO-1 and
SUMO-2/3 was determined in pachytene spermatocytes
from four individuals, whose ages range from 28 to 46 years;
each presented with a different clinical diagnosis (Table I).
Patient A was diagnosed with obstructive azoospermia due to
congenital bilateral absence of the vas deferens with quali-
tatively normal spermatogenesis. This biopsy material was
used to represent a ‘control’ as this patient has qualitatively
normal meiosis, documented by histology and sperm retrieval.
No less than 100 spermatocytes were analyzed from each
individual to determine intra- and inter-individual staining pat-
terns among the present sample. A total of 587 cells were
collected for SUMO-1 analysis and 780 for SUMO-2/3 analy-
sis. In addition to our prior observations (Vigodner et al.,
2006), three novel SUMO-1 staining patterns were identiﬁed.
SUMO-1 forms three different patterns during pachytene
Three meiosis-speciﬁc events are conserved across species:
pairing of duplicated chromosomes, SC formation that tethers
the paired homologues and homologous recombination, the
physical exchange of DNA between homologous chromo-
somes, not sister chromatids. Previously, we localized
SUMO-1 within human spermatocytes at pachytene (Vigodner
et al., 2006). Herein, we demonstrate that speciﬁc SCPs, SCP1
and SCP2, are SUMOylated in the human testis. To further
characterize its potential roles, SUMO-1 was visualized in con-
jugation with other markers of the pachytene stage and chro-
mosomal structural components, SCPs and centromeres. For
all individuals analyzed, there was a subset of pachytene
cells that showed a linear pattern co-localized with the SC of
all autosomal chromosomes (Fig. 1A–C). When present in
its linear form, SUMO-1, is not typically present in the
g-H2AX and BRCA1-labeled sex body; nor is it associated
with synaptic defects (e.g. gaps or splits) often displayed at
the centromeric heterochromatin of human chromosomes 1
and 9 (Fig. 1) (Barlow and Hulte ´n, 1996; Sun et al., 2005;
Codina-Pascual et al., 2006). The SUMO-1 linear pattern
was characteristic and maintained in spermatocytes even
when SCP3 was not labeled concurrently (Fig. 1D).
In a second subset of pachytene spermatocytes, SUMO-1 pre-
sented as a large, densely stained, cloud-like display at
one-to-ﬁve nuclear areas (Fig. 1E–H). These focal SUMO-1
associations were typically located at or near centromeric hetero-
chromatic regions, as determined with either SCP3 or SCP1 and
centromeres. FISH analysis showed these to be associated most
often with chromosome 9 (9qh), chromosome 1 (1qh) and, to a
lesser extent, several acrocentric chromosomes, which were
not further identiﬁed. However, SUMO-1 associations with
chromosomes other than 9 or 1 were lighter and more diffuse.
In all but one sample, a large subset of pachytene cells dis-
played both morphologies (Fig. 1I–K). In such dual patterned
cells, SUMO-1 was present in both its linear form coincident to
the SC and focally at the centromeric heterochromatin of
chromosomes 9 and 1.
In experiments with recombinant protein-neutralized anti-
sera, the characteristic SUMO-1 patterns were abolished in
focal and centromeric regions (data not shown).
The ratio of the three distinctive SUMO-1 patterns differs as
pachytene progresses
Pachytene cells were substaged based on sex body morphology
using the criterion that early pachytene display the X and Y
Brown et al.
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interwoven and knotted as pachytene progresses. Late pachy-
tene cells characteristically have a very tightly knotted, easily
identiﬁable sex body. Overall analyses of the data indicated
that the incidence of the three SUMO-1 patterns changed with
progression through pachytene. Combined data showed that at
Figure 1: During early pachytene, SUMO-1 is observed in three different patterns.
Human spermatocytes were analyzed for SUMO-1 (green), SC protein (SCP)3 (red; B and C, F–H, J and K) and centromeres (blue). (A)
SUMO-1 forms light, dotted linear structures similar to those identiﬁed as lateral SC elements by SCP3. (B) SUMO-1 seen in linear structures
in early human pachytene spermatocytes. Merging of both SUMO-1 and SCP3 (C) showed co-localization on autosomal chromosomes. SUMO-1
was co-localized with the SC only at synapsed regions; asynapsed SCP3 negative regions are also SUMO-1 negative (inset of individual auto-
somal chromosome in C). The paired sex body is also devoid of SUMO-1 (arrowhead), except at the pseudo-autosomal region, where there is
a small region of SUMO-1 (asterisk). (D) Another early pachytene spermatocyte that SUMO-1 displays linear structures in the absence of
SCP3. X and Y chromosomes are labeled by BRCA-1 (red). In a second subset of human pachytene spermatocytes, SUMO-1 is consistently
observed as a large, dense focus at or near the centromere of chromosome 9. (E) SUMO-1 has one large, extremely bright signal, which
when merged with the SCP3 and centromere signals (G) is found to associate at the centromeric region of an autosomal chromosome. In this
cell, SUMO-1 also has three lighter, secondary signals that also associate near autosomal centromeres and two small foci that are co-localized
with the sex body. Identiﬁcation of human chromosomes 1 and 9 by chromosome-speciﬁc FISH analysis demonstrate that the largest and brightest
SUMO-1 signal in E is always associated at or near the centromeric region of chromosome 9 (magenta FISH signal in H). The second FISH signal,
that of human chromosome 1 (white; H) shows a co-localization of chromosome 1 with the largest secondary SUMO-1 focal association.
Additionally, merging of the SUMO-1 image with SCs and centromeres showed that lighter secondary SUMO-1 signals were associated with
unidentiﬁed human acrocentric chromosomes (arrow). In a fourth mid-pachytene human spermatocyte (I–K), a third distinct SUMO-1 pattern
can be resolved: linear structures co-localized with synapsed SCs, a single focal association at chromosome 9 and co-localized centromeric
signals on all autosomal chromosomes. All images,  1000.
Table I. Patient sample demographics with SUMO-1 and SUMO-2/3 pattern distribution.
ID Age (years) Spermatogenesis/diagnosis















A 34 Normal; obstructed
b Yes 21 (19) 38 (35) 50 (46) 55 (24) 119 (52) 12 (5) 43 (19)
B 28 Hypospermatogenesis No 61 (59) 38 (36) 5 (5) 99 (48) 34 (16) 1 (0) 74 (36)
C 37 Hypogonadotrophic hypogonadism
c No 41 (23) 39 (21) 103 (56) 78 (39) 94 (47) 22 (11) 7 (3)
D 46 Normal; non-tumor tissue
d No 79 (45) 57 (33) 38 (22) 56 (39) 57 (40) 5 (4) 24 (17)
aClinical ﬁndings including histopathology.
bCBAVD (obstructed); congenital bilateral absence of the vas deferens, absence of cystic ﬁbrosis disease.
cKallmann syndrome.
dNormal spermatogenesis in tissue from patient with a seminoma.
ART, assisted reproduction technology.
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focal or dual patterns was 58%, 3% and 40%, respectively.
As cells entered mid-pachytene, the ratios changed slightly
for linear structures and dual patterns, decreasing to 48%
and increasing to 49%, respectively, whereas solely focal
associations remained unchanged (2.25%). In contrast, sperma-
tocytes in late pachytene showed a marked reversal in SUMO-1
patterns. Strikingly, late pachytene cells showed solely focal
associations in 54% of cells when compared with the low inci-
dence(2–3%)inearlyormid-pachytene.Linear-onlystructures
decreased to 13%, a 45% decrease from early pachytene; sper-
matocytes with dual patterns also decreased (33%).
Characterizing the presence of SUMO-1
To determine a time course for the presence of SUMO-1 during
meiotic prophase, leptotene, zygotene and diplotene cells based
on the morphology of the SC were analyzed. SUMO-1 was not
detected prior to the zygotene–pachytene transition (data not
shown). Diplotene is the shortest prophase substage and sperma-
tocytes at this stage are difﬁcult to ﬁnd, detectable in only 0.5%
of prophase cells; we did not identify any cells at diplotene. Of
the prophase cells analyzed, SUMO-1 was only detected in cells
at the zygotene–pachytene transition and pachytene cells, those
with complete synapsis of the autosomal chromosomes. Pre-
viously, this laboratory reported that SUMO-1 is often observed
near or at the sex body during pachytene (Vigodner and Morris,
2005). Our current study conﬁrms and expands on these ﬁndings
to now include the timing of speciﬁc substages, notably late
pachytene, after distinct formation of the sex body.
To determine whether linear SUMO-1 was a product of the
formation of the SC or associated with the complete SC,
SUMO-1 was characterized along with SCP1, a component
of the mammalian central element. SUMO-1 did not follow a
staining pattern similar to SCP1 during the formation of the
SC, short linear structures that are polymerized during zygo-
tene to form long, continuous linear structures at pachytene.
Rather, SUMO-1 appeared co-localized with SCP1 only after
synapsis was complete (data not shown).
For spermatocytes from Patients B and C, we assessed the
recombination frequency using MLH1, a mismatch repair
protein; normal range reported for MLH1 foci is between
46.2+3.3 and 52.8+4.8 foci (Lynn et al., 2002; Sun et al.,
2005). Our samples were both well within the established
norm; Patient B had a mean number of 52 foci and Patient C,
a mean of 50 MLH foci per cell. This suggests that variable
SUMOylation within pachytene cells does not reﬂect aberrant
recombination frequency.
SC proteins are SUMOylated
Using the protein lysates from each of the whole human testis
obtained from two adult males with normal spermatogenesis,
SUMOylation of the SC proteins was demonstrated using IP
analyses with both anti-SUMO-1 and SCP1 antisera. We ident-
iﬁed SUMOylated forms of SCP1 and SCP2, and in the com-
pleted tripartite SUMOylated SC structure (Fig. 2). Although
SUMOylation by SUMO-1 was demonstrated for the SC
complex and SCP1 and SCP2, in this study, we found no evi-
dence for SUMOylation of SCP3 by SUMO-1.
SUMO-2/3 is present in human meiotic spermatocytes
Human samples previously prepared for pachytene analysis
were labeled for SCP3, centromeres and SUMO-2/3. In all of
the samples analyzed, SUMO-2/3 was identiﬁed in some, but
not all, pachytene cells. Additionally, in contrast to SUMO-1,
which was not detectable prior to pachytene, SUMO-2/3 was
observed in cells as early as leptotene and zygotene (Fig. 3A).
Strikingly, no linear patterns were detected for SUMO-2/3.
Similar to SUMO-1, SUMO-2/3 was localized in two predomi-
nant patterns: a single, dense cloud-like array near the centro-
mere of a particular chromosome (Fig. 3B–F), similarly
labeled focal associations, and individual foci co-localized
with the autosomal centromeres (Fig. 3G–L). FISH analysis
conﬁrmed that analogous to the focal associations identiﬁed
with SUMO-1, the dense focal associations of SUMO-2/3
were nearly always associated with the centromeric region of
chromosome 9 (Fig. 3F). When combined, the data showed
that focal associations were identiﬁed in 39% (n ¼ 304/780)
and centromeric associations in 37% (n ¼ 288/780) of all ana-
lyzed nuclei. SUMO-2/3 was not detectable in 19% of sperma-
tocytes (n ¼ 148/780). The remainder of cells (5%; n ¼ 40/
780) was scored as having somewhat diffuse, ‘scattered’ punc-
tuate SUMO-2/3 staining patterns.
To our knowledge, these data are the ﬁrst observations indi-
cating that SUMO-2/3 is speciﬁcally involved in the meiotic
process of human spermatogenesis.
Analysis of SUMO-1 and SUMO-2/3 showed that SUMOy-
lation patterns vary between individuals with different clinical
presentations, and a distinctively different SUMO-2/3 pattern
was observed for Patient B compared with the others (see
Supplementary Figure 1, and chi-square analyses in Sup-
plementary Data).
Figure 2: The human SC and proteins SCP1 and SCP2, but not SCP3,
are SUMOylated in the testis of normal adult men.
Individual protein extracts were prepared from the whole testis of two
normal adult men (hT1 and hT2); Ø, no-protein extract but IP exper-
imental procedures in parallel; neat extract:- ,no IP; hT1,n o r m a l
human testis protein, 1 mg sample split for IP [500 mg with
anti-SUMO-1 (Zymed) or anti-SCP1 (Novus) antisera]. Illustrated are
the results following transfer of proteins electrophoresed using a 3–
8% polyacrylamide gel. Human SCP1 (lanes 5 and 6: predicted/
observed 114 kDa; 130 kDa observed, lanes 2 and 4); human SCP2
(predicted, 176 kDa; observed, 270 kDa, lanes 2, 4–6); human
SCP3 (predicted/observed 34 kDa, lanes 2, 4–6). Lower inset:
Westernanalysis,lanes5and6;detectionofSCP3usingNovusantisera
inthe non-IPsamples hT1 and hT2,different exposure; companionlanes
2and4dataare notshownduetonon-linearoverexposure.Bothb-actin
and SCP-1 were equally detected in pre-IP samples (not shown).
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In this study, we further delineate the relationships between
SUMOs and SUMOylation in human male meiosis. The dis-
tinct subcellular nuclear localization patterns identiﬁed pre-
viously for SUMO-1 (Vigodner et al., 2006) are further
characterized and the ﬁrst observations of SUMO-2/3i n
human pachytene spermatocytes are demonstrated. We show
that SCP1 and SCP2 are SUMOylated by SUMO-1 conju-
gation. Characterization of pachytene substages now clearly
demonstrates linear patterns of SUMO-1 in early pachytene,
a dual morphology during mid-pachytene, which may consti-
tute a transitional stage and, at late pachytene, solely focal
associations at 1qh and 9qh. In the testis of fertile adult men,
SCP1, SCP2 and the complex are SUMOylated by SUMO-1.
In this study, we did not detect SUMOylation of SCP3.
SUMO-1 appears associated in the mature complex with
SCP3 by the highly structured scaffold. Using the reported




multiple high probability SUMOylation sites are predicted.
On the basis of such modeling, SCP1 (NP_003167.2) has
nine potential SUMO sites and SCP2 (NP_055073.2) has
eight potential sites. Given our ﬁndings, interestingly SCP3
(NP_710161) has only one potential site. These predictions
Figure 3: SUMO-2/3 is identiﬁed in human pachytene spermatocytes.
Meiotic spermatocytes were triple-labeled for SUMO-2/3(green), SCP3 (red) and centromere (blue). SUMO-2/3 is detected in a scattered pattern
in meiosis as early as leptotene (A). In some pachytene cells (B–F), SUMO-2/3 (alone in B, merged with centromeres in C, and merged with SCs
and centromeres in E) appears as a bright, dense cloud at, or near, the centromere of human chromosome 9 (magenta FISH signal in F); smaller
and lighter signals associate with the sex body (arrowhead) and the centromeric region of an unidentiﬁed chromosome. In a second pachytene cell
(G–L), SUMO-2/3 forms small punctate foci similar to meiotic centromeres (G and J); merging the two images (I and L) shows complete
co-localization of both signals at all centromeres. This cell also has a small, brightly stained focal association (arrow). SCs and centromeres
are shown in D and K, respectively. All images,  1000.
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2855and our results are therefore consistent with an important role
for SUMOylation in the post-translational modiﬁcation of the
SC, especially one likely to involve both SCP1 and SCP2.
Inallsamplesanalyzed,themajorityofspermatocyteshada
dense SUMO-1 localization at or near the centromeric region
of chromosome 9, whereas less frequently and abundantly at
chromosome 1. Synaptic defects, incomplete synapsis, synap-
ticdiscontinuitiesandasynapsisareoftenidentiﬁedininfertile
male patients and are thought to be associated with reduced
fertility (Judis et al., 2004; Sun et al., 2004; Guichaoua
etal.,2005;Codina-Pascualetal.,2006).Humanchromosome
9 has the largest autosomal region of centric heterochromatin
of all human chromosomes; others are chromosomes 1 and 16
(Madon et al., 2005).The consistent SUMOylation ofthecen-
tromeric heterochromatin of human chromosome 9 is note-
worthy because of this unusual genomic structure. It has
been previously shown that these regions are the last to
synapseandmay result inspermatogeneicarrest due to synap-
tic anomalies (Antonelli et al., 2000; Codina-Pascual et al.,
2006). Gaps and synaptic discontinuities were often observed
in our sample population; however, there was no apparent
meiotic or spermatogeneic disruptions reﬂected in our
SUMOylation data. SUMOylation near 9qh was observed in
cells with or without synaptic gaps. We propose that the tar-
getedSUMOylationofmoleculesherehasaprotectiveadvan-
tageforprogressionthroughpachytene.HowtheSUMOylated
proteins, or SUMOs, precisely coordinate this response
remains to be determined.
Analysis of both SUMO-1 and SUMO-2/3 demonstrates
that SUMOylation patterns vary in individuals with particular
clinical presentations (Table I and Supplementary Data,
chi-square analyses). It remains unclear whether the SUMOy-
lation patterns strictly correlate with a particular cause of infer-
tility or represent, in part, variations on a biological theme.
Strikingly, a distinctively different SUMO-2/3 pattern was
observed for Patient B in comparison with all others (see Sup-
plementary Figure 1). Interestingly, this patient exhibited an
apparent hypoSUMOylation pattern, remarkable for its con-
spicuous lack of SUMO-2/3, particularly at the centromeric
heterochromatin of human chromosome 9. Of note, Patient B
had severely defective sperm production with azoospermia
and hypospermatogenesis on testicular histology. Although
there is no single measure of defective meiosis, patients with
severe hypospermatogenesis may be at increased risk for
having disordered meiosis (Gonsalves et al., 2004). In this
study,theotherpatientsallshowafairlyconsistentproportion
of cells with an easily identiﬁed SUMO-2/3 pattern, staining
atallcentromeresor focalassociationsathuman chromosome
9 between 75% and 85% of all pachytene spermatocytes. The
remaindershowedeithernodetectableSUMO-2/3stainingor
ascatteredpatternwithvaryingamounts.Incontrast,PatientB
displayed an overall decrease in the incidence of SUMO-2/3
stained cells; 64% showed SUMO-2/3 associated with the
centromeres or focal association at 9qh. For pachytene sper-
matocytes that are SUMOylated, a considerably greater
proportion of cells displayed a universal centromeric associ-
ation, perhaps at the expense of focal association at 9qh,
which showed an overall frequency of 13%; the range for the
other samples was 29–40%. Of the other 36% of the cells
not easily deﬁned, ,1% showed a scattered SUMO-2/3
pattern, with SUMO-2/3 undetectable in most cells.
When comparing the frequency of SUMO-1 morphologies
(linear, focal, dual and other) among all pachytene spermato-
cytes from the four samples, there are striking apparent differ-
ences between them. Although there is no overall decrease in
SUMOylationbySUMO-1inPatientBandthefocalassociation
ofSUMO-1atthecentromericheterochromatinofchromosomes
9 and 1 appears within the normal range, there is a sizeable
increaseinthefrequencyof‘other’SUMO-1morphologiescom-
pared with the other patients. This patient also shows a compar-
able decrease in the cells with the dual pattern. Though the
immunodetection pattern for SUMO-1 appears individual-
speciﬁc, the SUMOylation pattern of both SUMO-1 and
SUMO-2/3 in pachytene spermatocytes from Patient B is sug-
gestive of hypoSUMOylation, a ﬁnding that may correlate
with the clinical observation of hypospermatogenesis.
Of further note is Patient C, diagnosed with Kallmann syn-
drome, whose germ cells appear to be hyperSUMOylated by
SUMO-2/3 in comparison with those of the others evaluated
with different diagnoses. Kallmann syndrome is an X-linked
disorder associated with disruption in the hormone GnRH pro-
duction, resulting in a lack of FSH and LH and hypogonado-
trophic hypogonadism, conditions represented by both
reduction and impairment in the ﬁdelity of spermatogenesis
(Diemer and Desjardins, 1999). Patients diagnosed with Kall-
mann syndrome are typically treated with testosterone
therapy toinducepubertyand secondary male sexual character-
istics (Diemer and Desjardins, 1999). Patient C was sub-
sequently treated with HCG and FSH hormone therapy to
induce spermatogenesis prior to TESE (Raivio et al., 2007).
This individual shows an overall increased SUMOylation by
SUMO-2/3,speciﬁcally inthe‘scatter’pattern(Supplementary
Figure 1, panel II, C). Patient C shows a 10% increase in the
total number of pachytene cells with identiﬁable SUMO-2/3
stainingwhencompared withthecontrolindividual(PatientA).
In conclusion, we have found novel SUMOylation patterns
within human male spermatocytes at the pachytene stage of
meiosis. Our data are consistent with a role for SUMO-1 in
maintenance of the SC scaffold. Moreover, focal associations
at late pachytene directed to the centromeric heterochromatin
for particular chromosomes are suggestive of a role in protec-
tion of chromosomes with synaptic irregularities. Separate and
speciﬁc roles for SUMO-1 as cells progress through pachytene
are indicated by our ﬁndings. Importantly, we show that in the
normal human testis, the SC, and SCP1, SCP2 but not SCP3 are
SUMOylated. Our current studies are the ﬁrst to demonstrate
that SUMOylation by SUMO-2/3 occurs in human spermato-
cytes. Taken together, these data suggest that SUMOylation
patterns can be correlated with aberrant meiotic phenotypes
in men, ﬁndings that require further investigation to establish
causality in male infertility.
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